Researchers at the University of Pennsylvania School of Medicine discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients.
The disruption to this protein that conveys ions from lung cells to airways causes thick mucus to buildup inside the lung. The finding suggests a new therapeutic target for treating lung infections in some cystic fibrosis (CF) patients.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.huliq.com/18934/new-approach-to-cystic-fibrosis-treatment">http://www.huliq.com/18934/new...tic-fibrosis-treatment</a>
The disruption to this protein that conveys ions from lung cells to airways causes thick mucus to buildup inside the lung. The finding suggests a new therapeutic target for treating lung infections in some cystic fibrosis (CF) patients.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.huliq.com/18934/new-approach-to-cystic-fibrosis-treatment">http://www.huliq.com/18934/new...tic-fibrosis-treatment</a>